Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-17

Clinical Trial Update: Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral sulopenem-etzadroxil/probenecid to ciprofloxacin for uncomplicated urinary tract infections in adult women; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprofloxacin (Ciprofloxacin hydrochloride)
  • Sulopenem etzadroxil/probenecid (sulopenem etzadroxil/probenecid)

Snippet

Sponsor: Iterum Therapeutics, International Limited | Conditions: Uncomplicated Urinary Tract Infections | Phase 3 | Status: COMPLETED | Results posted: 2020-12-17